期刊文献+

基质金属蛋白酶及其抑制剂与鼻咽癌的侵袭性的关系 被引量:4

Relationship of MMP-2, 9 and TIMP-1, 2 with the invasion and metastasis of nasopharyngeal carcinoma
下载PDF
导出
摘要 目的研究基质金属蛋白酶-2,9(matrix metalloproteinase-2,9,MMP-2,9)及组织基质金属蛋白酶抑制剂-1,2(timue inhibitors of the MMP-1,2,TIMP-1,2)与鼻咽癌侵袭的关系。方法用免疫组化S-P法,检测48例鼻咽癌组织及16例鼻咽炎组织中MMP-2,MMP-9,TIMP-1,TIMP-2的表达。结果 鼻咽癌与鼻咽炎两组病人TIMP-1,TIMP-2比较有统计学意义(P<0.01),随着鼻咽癌原发灶T分期的发展,TIMP-1有增加的趋势。结论TIMP-1可以作为监测鼻咽癌侵袭的参数之一。 Objective To investigate the relationship between the expression of matrix metalloproteinase-2, 9 (MMP-2, MMP-9), tissue inhibitor of matrix metalloproteinases-1, 2 (TIMP-1, TIMP-2) and the invasion and metastasis of nasopharyngeal carcinoma (NPC). Methods MMP-2, MMP-9, TIMP-1, and TIMP-2 protein expression in 48 NPC patients and 16 patients with nasopharyngeal mucositis were studied by immunohistochemical method. Results TIMP - 1 , TIMP - 2 protein expressions between the NPC and the nasopharyngeal mucositis were positively correlated ( P <0.05). With the progression of the primary region of NPC, the expression of TIMP-1 tended to increase. Conclusion The expression of TIMP-1 protein may be regarded as a sign of the progression of NPC.
出处 《中国耳鼻咽喉颅底外科杂志》 CAS 2003年第5期286-289,共4页 Chinese Journal of Otorhinolaryngology-skull Base Surgery
关键词 基质金属蛋白酶 组织基质金属蛋白酶抑制剂 鼻咽肿瘤 病理学 肿瘤浸润力 鼻咽癌 侵袭性 Matrix metalloproteinases (MMPs) Tissue inhibitors of matrix metalloproteinases (TIMPs) Nasopha-ryngeal neoplasms/nathor Neoplosm invasireness
  • 相关文献

参考文献9

  • 1张欣欣,郭永清,叶青,杨占泉,董震.基质金属蛋白酶MMP9和MMP2与鼻咽癌转移的相关性研究[J].临床耳鼻咽喉科杂志,1999,13(8):356-358. 被引量:19
  • 2Huang GW, Manori S, Li JE, et al. The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasoplmryngeal carcinoma[J]. Laryngoscope, 2000, 110: 2066-2069.
  • 3Magary SP, Ryan MW, Tarnuzze RW, et al. Expression of matrix metalloproteinases and tissue inhibitor of metallopmteinases in laryngeal and pharyngeal squamous cell carcinoma: A quantitative analysis[J]. Otolaryrgol Head Neck Stag, 2000, 122(5) : 712 -716.
  • 4Anne Talvensaari-Mattila,Meeri Apaja-sarkkinen,Matti hoyhtya,et al .Matrix metalloproteinase -2 immunoreactive protein appears early in cervical epithelial dedifferentiation[J].Gynecologic oncology , 1999,72: 306-311.
  • 5Tsuldfuji R, Tagawa K, Hatamochi A, et al. Expression of Matrix Metalloproteinase-1,-2 and-3 in squarnous cell carcinoma and actinic keratosis. British Journal of Cancer, 1999, 80(7): 1087- 1091.
  • 6Tokumaru Y, Fujii M, Otani Y, et al. Action of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts[J]. Cancer Lett, 2000, 150(1): 15-21.
  • 7Galateau SaUe FB, Luna RE, Horiba K, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteimse in bronchial squmous preinvasive lesions[ J ]. Hum-Pathol, 2000, 31 ( 3 ) : 296- 305.
  • 8Nuovo GJ, MaeConnel PB, Simsir A, et al. Correlation of the in sire detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma[J]. Cancer Res, 1995, 55(15): 267-275.
  • 9Ylisirnio S, Floyhtya M, Turpeenniemi Hujianen T. Sermn Matrix Metalloproteinases-2, 9 and tissue inhibitors of metalloproteinases-1, 2 in lung eancer-TIMP-1 as a prognostic marker[J].Anti Cancer Res, 2000, 20(2b): 1311- 1316.

二级参考文献1

  • 1Zeng Z S,Br J Cancer,1995年,72卷,575页

共引文献18

同被引文献60

  • 1李琦,李湘平,姚连生.基质金属蛋白酶-2,9在下咽癌中的表达及其与淋巴结转移的相关性[J].临床耳鼻咽喉科杂志,2004,18(6):324-326. 被引量:5
  • 2陈忠华,欧阳学农,季天海,余英豪.基质金属蛋白酶及其抑制剂与咽喉部黑色素瘤浸润和转移的分子机制[J].中国误诊学杂志,2006,6(15):2863-2866. 被引量:1
  • 3Liotta L. Isolation of a protein that stimulates blood vessel growth[J]. Nature, 1985, 318(6041): 14.
  • 4Stetler-Stevenson WG. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention[J]. J Clin Invest, 1999, 103(9): 1237-1241.
  • 5Sakata K, Satoh M, Someya M, et al. Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma[J]. Cancer, 2004, 100(2): 356-365.
  • 6Vasala K, Paakko P, Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer[J]. Urology, 2003, 62(5): 952-957.
  • 7Bogusiewicz M, Stryjecka-Zimmer M, Szymanski M, et al. Activity of matrix metalloproteinases-2 and -9 in advanced laryngeal cancer[J]. Otolaryngol Head Neck Surg, 2003, 128(1): 132-136.
  • 8Liotta LA,Steeg PS,Stetler-Stevenson WG.Cancer metastasis and angiogenesis:an imbalance of positive and negative regulation[J].Cell,1991,64(2):327-336.
  • 9Bogusiewicz M,Stryjecka-Zimmer M,Szymanski M,et al.Activity of matrix metalloproteinases-2 and-9 in advanced laryngeal cancer[J].Otolaryngol Head Neck Surg,2003,128(1):132-136.
  • 10Maskos K.Crystal structures of MMPs in complex with physiological and pharmacological inhibitors[J].Biochimie,2005,87(3-4):249-263.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部